— Know what they know.
Not Investment Advice

NVCT NASDAQ

Nuvectis Pharma, Inc.
1W: -12.1% 1M: +24.0% 3M: +29.3% YTD: +28.6% 1Y: +2.7% 3Y: -35.3%
$10.35
-0.59 (-5.39%)
 
Weekly Expected Move ±12.6%
$8 $10 $11 $12 $14
NASDAQ · Healthcare · Biotechnology · Alpha Radar Buy · Power 60 · $274.5M mcap · 15M float · 0.464% daily turnover · Short 64% of daily vol

📊 Key Metrics

TTM
$0M
Revenue
+0.0% YoY
$-27M
Net Income
-34.7% YoY
$-18M
Free Cash Flow
-52.1% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-193.1%
ROA-108.0%
ROIC168.9%

Valuation

P/E-8.9
P/B17.0
EV/EBITDA-5.3

Leverage

Debt/Equity0.00
Current Ratio2.38
Interest Cov.0.0x

Quality Scores

Piotroski F3/9
Altman Z1.52
Beneish M0.00

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms